{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:09:57Z","timestamp":1792480197208,"version":"4.5.0"},"reference-count":75,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/23191-6"],"award-info":[{"award-number":["2013\/23191-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Glucocorticoids represent some of the most prescribed drugs that are widely used in the treatment of neuromuscular diseases, but their usage leads to side effects such as muscle atrophy. However, different synthetic glucocorticoids can lead to different muscle effects, depending upon its chemical formulation. Here, we intended to demonstrate the muscle histologic and molecular effects of administering different glucocorticoids in equivalency and different dosages. Methods: Seventy male Wistar rats distributed into seven groups received different glucocorticoids in equivalency for ten days or saline solution. The study groups were: Control group (CT) saline solution; dexamethasone (DX) 1.25 or 2.5 mg\/kg\/day; methylprednisolone (MP) 6.7 or 13.3mg\/kg\/day; and deflazacort (DC) 10 or 20 mg\/kg\/day. At the end of the study, the animals were euthanized, and the tibialis anterior and gastrocnemius muscles were collected for metachromatic ATPase (Cross-sectional area (CSA) measurement), Western blotting (protein expression of IGF-1 and Ras\/Raf\/MEK\/ERK pathways) and RT-PCR (MYOSTATIN, MuRF-1, Atrogin-1, REDD-1, REDD-2, MYOD, MYOG and IRS1\/2 genes expression) experiments. Results: Muscle atrophy occurred preferentially in type 2B fibers in all glucocorticoid treated groups. DC on 10 mg\/kg\/day was less harmful to type 2B fibers CSA than other doses and types of synthetic glucocorticoids. In type 1 fibers CSA, lower doses of DC and DX were more harmful than high doses. DX had a greater effect on the IGF-1 pathway than other glucocorticoids. MP more significantly affected P-ERK1\/2 expression, muscle fiber switching (fast-to-slow), and expression of REDD1 and MyoD genes than other glucocorticoids. Compared to DX and MP, DC had less of an effect on the expression of atrogenes (MURF-1 and Atrogin-1) despite increased MYOSTATIN and decreased IRS-2 genes expression. Conclusions: Different glucocorticoids appears to cause muscle atrophy affecting secondarily different signaling mechanisms. MP is more likely to affect body\/muscles mass, MEK\/ERK pathway and fiber type transition, DX the IGF-1 pathway and IRS1\/2 expression. DC had the smallest effect on muscle atrophic response possibly due a delayed timing on atrogenes response.<\/jats:p>","DOI":"10.3390\/cells8050406","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T03:15:22Z","timestamp":1556766922000},"page":"406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-9262","authenticated-orcid":false,"given":"Alan","family":"Fappi","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7685-8180","authenticated-orcid":false,"given":"Juliana de Carvalho","family":"Neves","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Nunes","family":"Sanches","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-8517","authenticated-orcid":false,"given":"Pedro Victor","family":"Massaroto e Silva","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-965X","authenticated-orcid":false,"given":"Guilherme Yuiti","family":"Sikusawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1508-1259","authenticated-orcid":false,"given":"Thayane Pereira Correa","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Chadi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-6760","authenticated-orcid":false,"given":"Edmar","family":"Zanoteli","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, S\u00e3o Paulo, SP 01246-904, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000359984","article-title":"Glucocorticoids","volume":"100","author":"Barnes","year":"2014","journal-title":"Chem. Immunol. Allergy."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1681.2003.03867.x","article-title":"Extra-adrenal production of corticosteroids","volume":"30","author":"Davies","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","article-title":"Extra-adrenal glucocorticoids and mineralocorticoids: Evidence for local synthesis, regulation, and function","volume":"301","author":"Taves","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2003-032026","article-title":"Glucocorticoid action networks\u2014An introduction to systems biology","volume":"89","author":"Chrousos","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","first-page":"R72","article-title":"The anti-inflammatory action of glucocorticoids and PDE4-inhibitors is mediated in part by modulation of MAPK signaling pathways","volume":"371","author":"Amon","year":"2005","journal-title":"N-S Arch. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nicolaides, N.C., Charmandari, E., Chrousos, G.P., and Kino, T. (2014). Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: Novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr. Disord., 14.","DOI":"10.1186\/1472-6823-14-71"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: Implications for management","volume":"25","author":"Moxley","year":"2010","journal-title":"J. Child. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2007.11.001","article-title":"Deflazacort use in Duchenne muscular dystrophy: An 8-year follow-up","volume":"38","author":"Houde","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol. Therapeut."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.biocel.2013.05.039","article-title":"Regulation of muscle protein synthesis and the effects of catabolic states","volume":"45","author":"Gordon","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2015.00012","article-title":"The regulation of muscle mass by endogenous glucocorticoids","volume":"6","author":"Braun","year":"2015","journal-title":"Front. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1096\/fj.06-6604com","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02405325","article-title":"Effects of Prednisone and Deflazacort on Mineral Metabolism and Parathyroid-Hormone Activity in Humans","volume":"36","author":"Gennari","year":"1984","journal-title":"Calcified Tissue Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF02554912","article-title":"Effects of prednisone and deflazacort on vertebral bone mass","volume":"37","author":"Gennari","year":"1985","journal-title":"Calcified Tissue Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1989.00390050082016","article-title":"Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone","volume":"149","author":"Pagano","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0387-7604(95)00015-1","article-title":"Deflazacort vs. prednisone in Duchenne muscular dystrophy: Trends of an ongoing study","volume":"17","author":"Reitter","year":"1995","journal-title":"Brain Dev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mus.20812","article-title":"The role of corticosteroids in muscular dystrophy: A critical appraisal","volume":"36","author":"Angelini","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: Study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.95.08050824","article-title":"Rat diaphragm contractility and histopathology are affected differently by low dose treatment with methylprednisolone and deflazacort","volume":"8","author":"Dekhuijzen","year":"1995","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7","article-title":"Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse","volume":"19","author":"Anderson","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.880090102","article-title":"A morphological\/biochemical study on the actions of corticosteroids on rat skeletal muscle","volume":"9","author":"Kelly","year":"1986","journal-title":"Muscle Nerve"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj2080147","article-title":"The differing responses of four muscle types to dexamethasone treatment in the rat","volume":"208","author":"Kelly","year":"1982","journal-title":"Biochem. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function","volume":"63","author":"Meikle","year":"1977","journal-title":"Am. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0019-5154.44786","article-title":"Deflazacort versus other glucocorticoids: A comparison","volume":"53","author":"Nayak","year":"2008","journal-title":"Indian J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10520299009105613","article-title":"A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC","volume":"65","author":"Ogilvie","year":"1990","journal-title":"Stain Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0962-8924(96)81024-5","article-title":"Insulin receptor substrate 1 and 2 (IRS1 and IRS2): What a tangled web we weave","volume":"6","author":"Waters","year":"1996","journal-title":"Trends Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00424-002-0939-1","article-title":"Blockades of mitogen-activated protein kinase and calcineurin both change fibre-type markers in skeletal muscle culture","volume":"445","author":"Higginson","year":"2002","journal-title":"Pflugers Arch."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1164\/ajrccm.153.6.8665051","article-title":"Effects of acute steroid administration on ventilatory and peripheral muscles in rats","volume":"153","author":"Nava","year":"1996","journal-title":"Am. J. Resp. Crit.Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nmd.2007.06.053","article-title":"Deflazacort induced severe skeletal muscle wasting and inguinal herniation in normal Beagle dogs","volume":"17","author":"Yoshimura","year":"2007","journal-title":"Neuromuscular Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.200702-296OC","article-title":"Effects of acute administration of corticosteroids during mechanical ventilation on rat diaphragm","volume":"178","author":"Maes","year":"2008","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1465-9921-11-178","article-title":"Corticosteroid effects on ventilator-induced diaphragm dysfunction in anesthetized rats depend on the dose administered","volume":"11","author":"Maes","year":"2010","journal-title":"Respir. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1740-8261.2011.01884.x","article-title":"Effect of glucocorticoid administration on adrenal gland size and sonographic appearance in beagle dogs","volume":"53","author":"Pey","year":"2012","journal-title":"Vet. Radiol. Ultrasound"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1210\/en.2009-1436","article-title":"Endocrine and physiological changes in response to chronic corticosterone: A potential model of the metabolic syndrome in mouse","volume":"151","author":"Karatsoreos","year":"2010","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1357-2725(98)00141-1","article-title":"Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle","volume":"31","author":"Jefferson","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1113\/jphysiol.2006.116715","article-title":"Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy","volume":"576","author":"Leger","year":"2006","journal-title":"J. Physiol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1469-185X.2010.00161.x","article-title":"Excitation-transcription coupling in skeletal muscle: The molecular pathways of exercise","volume":"86","author":"Gundersen","year":"2011","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mce.2009.05.020","article-title":"GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle","volume":"315","author":"Ciaraldi","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.1073\/pnas.1111334109","article-title":"Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling","volume":"109","author":"Kuo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/1078-0432.CCR-10-0434","article-title":"Insulin receptor substrate regulation of phosphoinositide 3-kinase","volume":"17","author":"Metz","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/embor.2009.93","article-title":"REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase","volume":"10","author":"Katiyar","year":"2009","journal-title":"EMBO Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(02)00706-2","article-title":"REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species","volume":"10","author":"Ellisen","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/BJ20050553","article-title":"Arsenite induces a cell stress-response gene, RTP801, through reactive oxygen species and transcription factors Elk-1 and CCAAT\/enhancer-binding protein","volume":"392","author":"Lin","year":"2005","journal-title":"Biochem. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"C542","DOI":"10.1152\/ajpcell.00192.2009","article-title":"p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting","volume":"298","author":"McClung","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nishida, H., Ikegami, A., Kaneko, C., Kakuma, H., Nishi, H., Tanaka, N., Aoyama, M., Usami, M., and Okimura, Y. (2015). Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128805"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","article-title":"REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy","volume":"307","author":"Britto","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","article-title":"Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jcp.25609","article-title":"Heat Stress Modulates Both Anabolic and Catabolic Signaling Pathways Preventing Dexamethasone-Induced Muscle Atrophy In Vitro","volume":"232","author":"Tsuchida","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00341.2014","article-title":"REDD2 expression in rat skeletal muscle correlates with nutrient-induced activation of mTORC1: Responses to aging, immobilization, and remobilization","volume":"308","author":"Kelleher","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jcb.22349","article-title":"Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes","volume":"108","author":"Frost","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCO.0b013e32833a5107","article-title":"Corticosteroids and muscle wasting: Role of transcription factors, nuclear cofactors, and hyperacetylation","volume":"13","author":"Hasselgren","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.bjp.0702036","article-title":"Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells","volume":"124","author":"Passaquin","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0898-6568(02)00007-4","article-title":"Modulation of the Ras\/Raf\/MEK\/ERK pathway by Ca(2+), and calmodulin","volume":"14","author":"Agell","year":"2002","journal-title":"Cell. Signal."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1096\/fj.07-097600","article-title":"Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling","volume":"22","author":"Shi","year":"2008","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/MCB.01071-14","article-title":"Muscle-derived extracellular signal-regulated kinases 1 and 2 are required for the maintenance of adult myofibers and their neuromuscular junctions","volume":"35","author":"Seaberg","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_65","first-page":"E118","article-title":"Glucocorticoid sites in skeletal muscle: Adrenalectomy, maturation, fiber type, and sex","volume":"247","author":"DuBois","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000229762","article-title":"Mechanisms of muscle atrophy induced by glucocorticoids","volume":"72","author":"Schakman","year":"2009","journal-title":"Horm. Res. Paediat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2015.12.016","article-title":"Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone","volume":"107","author":"Macedo","year":"2016","journal-title":"Steroids"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","article-title":"Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression","volume":"285","author":"Ma","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wang, R., Jiao, H., Zhao, J., Wang, X., and Lin, H. (2016). Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156225"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/BF02877711","article-title":"Deflazacort: A glucocorticoid with few metabolic adverse effects but important immunosuppressive activity","volume":"24","author":"Luquin","year":"2007","journal-title":"Adv. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00298432","article-title":"Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro","volume":"57","author":"Kasperk","year":"1995","journal-title":"Calcified Tissue Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s004670000337","article-title":"Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group","volume":"14","author":"Ferraris","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mus.26191","article-title":"Deflazacort versus prednisone\/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial","volume":"58","author":"Shieh","year":"2018","journal-title":"Muscle Nerve"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/5\/406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:48:37Z","timestamp":1760186917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/5\/406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["cells8050406"],"URL":"https:\/\/doi.org\/10.3390\/cells8050406","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}